0001835378False00018353782023-11-082023-11-080001835378us-gaap:CommonStockMember2023-11-082023-11-080001835378us-gaap:WarrantMember2023-11-082023-11-08


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 8, 2023
Innovid Corp.
(Exact name of registrant as specified in its charter)
Delaware001-4004887-3769599
(State or other jurisdiction
of incorporation or organization)
(Commission
File Number)
(I.R.S. Employer
Identification No.)

30 Irving Place, 12th Floor
New York, NY 10003
(Address of principal executive offices) (Zip Code)
(212) 966-7555
(Registrant’s telephone number, include area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.0001 per share
CTV
New York Stock Exchange
Warrants to purchase one share of common stock, each at an exercise price of $11.50 per shareCTVWSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02.     Results of Operations and Financial Condition.

On November 8, 2023, Innovid Corp. issued a press release announcing its financial results for the quarter ended September 30, 2023. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein to this item 2.02.

In accordance with General Instruction B.2 of Form 8-K, the information included under Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.



Item 9.01.     Financial Statements and Exhibits.

(d) Exhibits


Exhibit NoDescription
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document)





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INNOVID CORP.
Date: November 8, 2023By:/s/ Anthony Callini
Name:Anthony Callini
Title:Chief Financial Officer






Innovid Reports Q3 2023 Financial Results

Q3 revenue increased to $36.2 million, up 5% year-over-year
CTV revenue from Ad Serving and Personalization, up 9% year-over-year
Company raises full year 2023 guidance

NEW YORK, November 8, 2023 /PRNewswire/ -- Innovid Corp. (NYSE:CTV) (the "Company"), an independent advertising platform for delivery, personalization, and measurement of converged TV across linear, connected TV (CTV), and digital, today announced financial results for the third fiscal quarter ended September 30, 2023.
“I am pleased to report we delivered a strong third quarter - exceeding our prior guidance for both revenue and Adjusted EBITDA*, positioning us to raise our full year guidance,” said Zvika Netter, Co-Founder and CEO. "Importantly, we significantly increased Adjusted EBITDA* margins to 18%, up from 8% in the prior year period and we generated $4.1 million in positive Free Cash Flow* this quarter. Our Q3 results are evidence of our increased operational efficiency and our focus on profitable growth. Looking ahead, we are optimistic about future growth and our ability to expand our moat as a leader in building critical technology for the future of TV advertising.”


Third Quarter 2023 Financial Summary

Revenue increased to $36.2 million, reflecting year-over-year growth of 5%.
CTV revenue, from Ad Serving and Personalization, increased to $14.4 million, up 9% year-over-year.
Measurement contributed $8.4 million, up 8% year-over-year, representing 23% of revenue.
Net loss was $2.7 million, compared to a net loss of $11.8 million for the same period in 2022.
Adjusted EBITDA* more than doubled to $6.5 million, compared to $2.9 million for the same period in 2022, representing 18% Adjusted EBITDA margin.
Free cash flow* increased 78% to $4.1 million, compared to $2.3 million in the same period in 2022.
Cash and cash equivalents as of September 30, 2023 increased from the prior quarter by $4.3 million, to a total of $47.7 million.


Recent Business Highlights

CTV accounted for 55% of all video impressions served in Q3 2023.
Significant customer wins this quarter included Revlon, Fanatics, Bausch Health, and OnRunning.
Existing premium publisher partners such as NBC Universal expanded their usage commitment for our measurement solution to help prove the value of their inventory to advertisers.
We announced the launch of Instant Optimization, a machine-learning solution that empowers converged TV marketers with the ability to immediately optimize ad performance as the campaign is running.
Innovid will be hosting an Investor Day detailing the company's vision, market opportunities, and product innovation on November 30, 2023 in New York City. Please find additional information here.


Financial Outlook

Innovid is providing the following financial guidance for Q4 and full year 2023:
Q4 2023 revenue in a range between $35 million and $37 million.
Q4 2023 Adjusted EBITDA* in a range between $5.5 million and $7.5 million.

FY 2023 revenue in a range between $136 million and $138 million.
FY 2023 Adjusted EBITDA* in a range between $16.6 and $18.6 million for the full year with an Adjusted EBITDA margin* of at least 12% for the full year.









*See Use of Non-GAAP Financial Information and Reconciliation of GAAP to Non-GAAP Financial Measures table.

Conference Call

The Company will host a conference call and webcast to discuss third quarter 2023 financial
results today at 8:30 a.m. Eastern Time. Hosting the call will be Zvika Netter, Co-founder and Chief Executive Officer and Anthony Callini, Chief Financial Officer. The conference call will be available via webcast at investors.innovid.com. To participate via telephone, please dial 877-407-3211 (toll free) or 201-389-0862, and click here for international dial-ins. Following the call, a replay of the webcast will be available for 90 days on the Innovid Investor Relations website.
Non-GAAP Measures and Certain Operational Metrics

Innovid prepares unaudited interim condensed consolidated financial statements in accordance with U.S. generally accepted accounting principles ("GAAP"). Innovid also discloses and discusses non-GAAP financial measures such as Adjusted EBITDA and Adjusted EBITDA margin and Free Cash Flow.

We use Adjusted EBITDA, Adjusted EBITDA margin and Free Cash Flow as measures of operational efficiency to understand and evaluate our core business operations. We believe that these non-GAAP financial measures are also useful to investors for period-to-period comparisons of our core business. Additionally, these figures provide an understanding and evaluation of our trends when comparing our operating results, on a consistent basis, by excluding items that we do not believe are indicative of our core operating performance.

These non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for an analysis of our results as reported under GAAP. Some of the limitations of these measures are:
they do not reflect changes in, or cash requirements for, our working capital needs;
Adjusted EBITDA does not reflect our capital expenditures or future requirements for capital expenditures or contractual commitments;
they do not reflect costs of acquiring and integrating businesses, which will continue to be a part of our growth strategy;
they do not reflect one-time, non-recurring, bonus costs and third party costs associated with the SPAC merger transaction and regulatory filings;
they do not reflect goodwill impairment;
they do not reflect severance costs;
they do not reflect income tax expense or the cash requirements to pay income taxes;
they do not reflect our interest expense or the cash requirements necessary to service interest or principal payments on our debt; and
although depreciation and amortization are non-cash charges related mainly to intangible assets and amortization of software development costs, certain assets being depreciated and amortized will have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements.

Adjusted EBITDA is defined as net loss attributable to Innovid, excluding (1) depreciation, amortization and long-lived assets impairment, (2) goodwill impairment, (3) stock-based compensation, (4) finance (income) expenses, net, (5) transaction related expenses, (6) acquisition related expenses, (7) retention bonus expenses, (8) legal claims, (9) severance cost, (9) other, and (10) taxes on income.

We calculate Adjusted EBITDA margin as Adjusted EBITDA divided by total revenue.

We define Free Cash Flow as net cash provided by operating activities less capital expenditures.

2


Other companies in our industry may calculate the above described non-GAAP financial measures differently than we do, limiting their usefulness as a comparative measure. You should compensate for these limitations by relying primarily on our US GAAP results and using the non-GAAP financial measures only supplementally.

Innovid has provided a reconciliation of Adjusted EBITDA and Adjusted EBITDA margin to net (loss) income, the most directly comparable GAAP measure, for historical periods in the appendix hereto. We also have provided reconciliation of Free Cash Flow to net cash provided by operating activities. We are not able to provide a reconciliation of the projected Adjusted EBITDA or Adjusted EBITDA margin to expected net (loss) income attributable to Innovid for the fourth quarter of 2023 or the full-year 2023, without unreasonable effort. This is due to the unknown effect, timing, and potential significance of the effects of taxes on income in multiple jurisdictions, finance (income)/expenses including valuations, among others. These items have in the past, and may in the future, significantly affect GAAP results in a particular period.

Forward Looking Statements

This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1996. The Company's actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," "aim," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's expectations regarding its future financial results and expected growth. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results, including Innovid's ability to achieve and, if achieved, maintain profitability, decrease and/or changes in CTV audience viewership behavior, Innovid's failure to make the right investment decisions or to innovate and develop new solutions, inaccurate estimates or projections of future financial performance, Innovid's failure to manage growth effectively, the dependence of Innovid's revenues and business on the overall demand for advertising and a limited number of advertising agencies and advertisers, the actual or potential impacts of international conflicts and humanitarian crises on global markets, the rejection of digital advertising by consumers, future restrictions on Innovid's ability to collect, use and disclose data, market pressure resulting in a reduction of Innovid's revenues per impression, Innovid's failure to adequately scale its platform infrastructure, exposure to fines and liability if advertisers, publishers and data providers do not obtain necessary and requisite consents from consumers for Innovid to process their personal data, competition for employee talent, seasonal fluctuations in advertising activity, payment-related risks, interruptions or delays in services from third parties, errors, defects, or unintended performance problems in Innovid's platform, intense market competition, failure to comply with the terms of third party open source components, changes in tax laws or tax rulings, failure to maintain an effective system of internal controls over financial reporting, failure to comply with data privacy and data protection laws, infringement of third-party intellectual property rights, difficulty in enforcing Innovid's own intellectual property rights, system failures, security breaches or cyberattacks, additional financing if required may not be available, the volatility of the price of Innovid's common stock and warrants, and other important factors discussed under the caption "Risk Factors" in Innovid's Annual Report on Form 10-K filed with the SEC on March 3, 2023, as such factors may be updated from time to time in its other filings with the SEC, accessible on the SEC's website at www.sec.gov and the Investors Relations section of Innovid's website at investors.innovid.com. You should carefully consider the risks and uncertainties described in the documents filed by the Company from time to time with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Most of these factors are outside the Company's control and are difficult to predict. The Company cautions not to place undue reliance upon any forward-looking statements, including projections, which speak only as of the date made. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.

3



About Innovid
Innovid (NYSE: CTV) powers advertising delivery, personalization, and measurement across linear, connected TV (CTV) and digital for the world's largest brands. Through a global infrastructure that enables cross-platform ad serving, data-driven creative, and measurement, Innovid offers its clients always-on intelligence to optimize advertising investment across channels, platforms, screens, and devices. Innovid is an independent platform that leads the market in converged TV innovation, through proprietary technology and exclusive partnerships designed to reimagine TV advertising. Headquartered in New York City, Innovid serves a global client base through offices across the Americas, Europe, and Asia Pacific. To learn more, visit innovid.com or follow us on LinkedIn or Twitter.

Contacts

Investor Contact
Brinlea Johnson
IR@innovid.com

Media Contacts
Megan Garnett Coyle
megan@innovid.com

Caroline Yodice
cyodice@daddibrand.com



4


INNOVID, CORP. AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except stock and per stock data)

September 30, 2023

December 31, 2022
(Unaudited)
ASSETS


Cash and cash equivalents
$47,680 $37,541 
Short-term bank deposits— 10,000 
Trade receivables, net (allowance for credit losses of $270 and $65 at September 30, 2023, and December 31, 2022, respectively)43,559 43,653 
Prepaid expenses and other current assets
3,905 2,640 
Total current assets95,144 93,834 
Long-term deposit
253 277 
Long-term restricted deposits
387 430 
Property and equipment, net
18,097 14,322 
Goodwill
102,473 116,976 
Intangible assets, net26,529 29,918 
Operating lease right of use asset1,559 2,910 
Other non-current assets787 938 
Total non-current assets
150,085 165,771 
TOTAL ASSETS
$245,229 $259,605 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade payables3,325 3,361 
Employees and payroll accruals11,935 10,165 
Lease liabilities - current portion1,325 2,186 
Accrued expenses and other current liabilities5,183 5,474 
Total current liabilities21,768 21,186 
Long-term debt20,000 20,000 
Lease liabilities - non-current portion814 1,636 
Other non-current liabilities9,113 6,554 
Warrants liability613 4,301 
Total non-current liabilities30,540 32,491 
TOTAL LIABILITIES52,308 53,677 
COMMITMENTS AND CONTINGENT LIABILITIES
Common stock: $0.0001 par value - Authorized: 500,000,000 at September 30, 2023, and December 31, 2022; Issued and outstanding: 140,136,905 and 133,882,414 at September 30, 2023, and December 31, 2022, respectively13 13 
Additional paid-in capital374,047 356,801 
Accumulated deficit(181,139)(150,886)
Total stockholders’ equity192,921 205,928 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$245,229 $259,605 

5


INNOVID, CORP. AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except stock and per stock data)

Three months ended September 30,Nine months ended September 30,

2023202220232022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Revenues$36,234 $34,469 $101,265 $93,419 
Cost of revenues (1)8,428 8,534 25,284 21,811 
Research and development (1)6,486 7,312 20,479 24,276 
Sales and marketing (1)11,175 13,726 34,272 38,397 
General and administrative (1)9,753 9,046 28,327 30,456 
Depreciation, amortization and long-lived assets impairment4,714 1,882 8,808 3,481 
Goodwill impairment— — 14,503 — 
Operating loss(4,322)(6,031)(30,408)(25,002)
Finance (income) expenses, net(290)4,962 (3,013)(10,655)
Loss before taxes(4,032)(10,993)(27,395)(14,347)
Taxes on income(1,301)839 2,858 634 
Net loss(2,731)(11,832)(30,253)(14,981)
Net loss attributable to common stockholders$(2,731)$(11,832)$(30,253)$(14,981)
Net (loss) income per stock attributable to common stockholders
Basic and diluted$(0.02)$(0.09)$(0.22)$(0.12)
Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders
Basic and diluted139,607,389 132,959,511 137,826,099 129,768,724 

(1) Exclusive of depreciation, amortization, long-lived assets and goodwill impairment presented separately.



6




INNOVID, CORP. AND ITS SUBSIDIARIES CONDENSED STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY
(In thousands, except stock data)

Common stock
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Number
Amount
Balance as of December 31, 2021119,017,380 $12 $293,719 $(132,476)$161,255 
Common stock and equity awards issued for acquisition of TVS11,549,465 47,151 — 47,152 
Stock-based compensation— — 1,496 — 1,496 
Stock options exercised1,521,927 — 462 — 462 
Net loss— — — (7,449)(7,449)
Balance as of March 31, 2022 (unaudited)132,088,772 $13 $342,828 $(139,925)$202,916 
Stock-based compensation—  4,628 — 4,628 
Stock options exercised322,943 — 174 — 174 
Net income—  — 4,300 4,300 
Balance as of June 30, 2022 (unaudited)132,411,715 $13 $347,630 $(135,625)$212,018 
Stock-based compensation—  4,612 — 4,612 
Stock options exercised and RSUs vested1,080,799 — 181 — 181 
Net loss—  — (11,832)(11,832)
Balance as of September 30, 2022 (unaudited)133,492,514 $13 $352,423 $(147,457)$204,979 
Common stock
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Number
Amount
Balance as of December 31, 2022133,882,414 $13 $356,801 $(150,886)$205,928 
Stock-based compensation— — 4,897 — 4,897 
Stock options exercised and RSUs vested2,734,320 — 250 — 250 
Net loss— — — (8,563)(8,563)
Balance as of March 31, 2023 (unaudited)136,616,734 $13 $361,948 $(159,449)$202,512 
Stock-based compensation— — 5,658 — 5,658 
Stock options exercised and RSUs vested2,120,370 — 364 — 364 
Net loss— — — (18,959)(18,959)
Balance as of June 30, 2023 (unaudited)138,737,104 $13 $367,970 $(178,408)$189,575 
Stock-based compensation— — 5,919 — 5,919 
Stock options exercised and RSUs vested1,399,801 — 158 — 158 
Net loss— — — (2,731)(2,731)
Balance as of September 30, 2023 (unaudited)140,136,905 $13 $374,047 $(181,139)$192,921 


7


INNOVID, CORP. AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, except stock and per stock data)
Nine Months Ended September 30
20232022
Cash flows from operating activities:(Unaudited)(Unaudited)
Net loss$(30,253)$(14,981)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, amortization and long-lived assets impairment8,808 3,481 
Goodwill impairment14,503 — 
Stock-based compensation15,470 9,956 
Change in fair value of warrants(3,688)(11,382)
Changes in operating assets and liabilities
Trade receivables, net94 (1,294)
Prepaid expenses and other current assets(1,167)514 
Operating lease right of use assets1,351 1,332 
Trade payables(36)(1,032)
Employees and payroll accruals1,770 2,227 
Operating lease liabilities(1,683)(1,782)
Accrued expenses and other current liabilities2,268 2,872 
Net cash provided by / (used in) operating activities7,437 (10,089)
Cash flows from investing activities:
Acquisition of business, net of cash acquired— (99,568)
Internal use software capitalization(7,795)(6,975)
Purchase of property and equipment(395)(282)
Withdrawal of short-term bank deposits10,000 — 
Increase in deposits77 38 
Net cash provided by / (used in) investing activities1,887 (106,787)
Cash flows from financing activities:
Proceeds from loans20,000 9,000 
Repayment of loans(20,000)— 
Payment of SPAC merger transaction costs— (3,185)
Proceeds from exercise of options772 817 
Net cash provided by financing activities772 6,632 
Increase (decrease) in cash, cash equivalents, and restricted cash10,096 (110,243)
Cash, cash equivalents, and restricted cash at the beginning of the period37,971 157,158 
Cash, cash equivalents, and restricted cash at the end of the period$48,067 $46,915 
Supplemental disclosure of cash flows activities:
(1) Cash paid during the period for:
Income taxes paid, net of tax refunds$1,129 $727 
Interest$1,141 $371 
(2) Non-cash transactions:
Business combination consideration paid in stock$— $47,152 
Reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets
Cash and cash equivalents47,680 46,509 
Long-term restricted deposits387 406 
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows$48,067 $46,915 
8


Key Metrics and Non-GAAP Financial Measures
In addition to our results determined in accordance with US GAAP, we believe that certain non-GAAP financial measures, including Adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”), Adjusted EBITDA Margin and Free Cash Flow are useful in evaluating our business. The following table presents a reconciliation of Adjusted EBITDA, a non-GAAP financial measure, to the most directly comparable financial measure prepared in accordance with GAAP.

Adjusted EBITDA
Three months ended September 30,Nine months ended September 30,
(in thousands)2023202220232022
Net loss$(2,731)$(11,832)$(30,253)$(14,981)
Net loss margin(8)%(34)%(30)%(16)%
Depreciation, amortization and long-lived assets impairment4,714 1,882 8,808 3,481 
Goodwill impairment— — 14,503 — 
Stock-based compensation5,605 4,322 15,563 10,052 
Finance (income) expenses, net (a)(290)4,962 (3,013)(10,655)
Transaction related expenses (b)— — — 392 
Acquisition related expenses (c)— — — 4,971 
Retention bonus expenses (d)119 1,290 564 2,290 
Legal claims420 664 1,076 1,099 
Severance cost (e)— — 845 — 
Other(80)739 192 915 
Taxes on income(1,301)839 2,858 634 
Adjusted EBITDA
$6,456 $2,866 $11,143 $(1,802)
Adjusted EBITDA margin
17.8 %8.3 %11.0 %(1.9)%

(a) Finance income, net consists mostly of remeasurement related to revaluation of our warrants, remeasurement of our foreign subsidiary’s monetary
assets, liabilities and operating results, and our interest expense.
(b) Transaction related expenses consist of costs related to the SPAC merger transaction.
(c) Acquisition related expenses consists of professional fees associated with the acquisition of TVS.
(d) Retention bonus expenses consists of retention bonuses for TVS employees.
(e) Severance cost is related to the personnel reductions that occurred during the first quarter of 2023.

Free Cash Flow

We define Free Cash Flow as net cash provided by operating activities less capital expenditures.

Three months ended September 30,
Nine months ended September 30,
2023202220232022
Net cash provided by operating activities6,489 5,812 7,437 (10,089)
Capital expenditures(2,410)(3,520)(8,190)(7,257)
Free Cash Flow
$4,079 $2,292 $(753)$(17,346)
Operational Metrics
In addition, Innovid’s management considers the number of core clients, annual core clients retention and annual core clients net revenue retention in evaluating the performance of the business. These metrics are reported annually. Prior to our acquisition of TVS in 2022, our definition of a core client included only advertisers that generated at least $100,000 revenue in a twelfth-months period. Following our acquisition of TVS, we have included publishers as core clients.

9
v3.23.3
Cover
Nov. 08, 2023
Document Information [Line Items]  
Document Type 8-K
Document Period End Date Nov. 08, 2023
Entity Registrant Name Innovid Corp.
Entity Incorporation, State or Country Code DE
Entity File Number 001-40048
Entity Tax Identification Number 87-3769599
Entity Address, Address Line One 30 Irving Place
Entity Address, Address Line Two 12th Floor
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10003
City Area Code 212
Local Phone Number 966-7555
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001835378
Amendment Flag false
Common Stock  
Document Information [Line Items]  
Title of 12(b) Security Common stock, par value $0.0001 per share
Trading Symbol CTV
Security Exchange Name NYSE
Warrant  
Document Information [Line Items]  
Title of 12(b) Security Warrants to purchase one share of common stock, each at an exercise price of $11.50 per share
Trading Symbol CTVWS
Security Exchange Name NYSE

Innovid (NYSE:CTV)
Historical Stock Chart
Von Jan 2024 bis Feb 2024 Click Here for more Innovid Charts.
Innovid (NYSE:CTV)
Historical Stock Chart
Von Feb 2023 bis Feb 2024 Click Here for more Innovid Charts.